Alnylam Pharmaceuticals
ABOUT ALNYLAM
Our Science Is Changing the Way Medicine Treats DiseaseTM
Alnylam has led the translation of RNAi (RNA interference) from Nobel Prize-winning discovery into an innovative, entirely new class of medicines. Founded in 2002 by a team of distinguished life sciences leaders, Alnylam’s vision is to harness the potential of RNAi therapeutics to transform the lives of people living with diseases for which there are limited or inadequate treatment options. Our pioneering work has delivered the world’s first and only approved RNAi therapeutics—ONPATTRO® (patisiran) in 2018, GIVLAARI® (givosiran) in 2019, OXLUMO® (lumasiran) in 2020, and AMVUTTRA® (vutrisiran) in 2022. We are advancing a deep pipeline of innovative RNAi-based medicines in four therapeutic areas: genetic medicines, cardio-metabolic diseases, infectious diseases, and central nervous system (CNS) and ocular diseases.
What’s in a Name?
AL-NY-LAM. Our name may not be the easiest to pronounce, but once you learn it, you’ll never forget it. Alnylam is derived from “Alnilam,” the bright center star in the constellation Orion’s belt, which has been used by navigators for thousands of years and symbolizes our passion for discovery.
RNAi Therapeutics—An Innovative New Class of Medicines
Medicines based on RNAi work by “silencing” or disabling the production (“expression”) of the genes that cause specific diseases. In doing so, RNAi therapeutics work “upstream” of most other classes of medicines, such as small molecules and monoclonal antibodies, by targeting the “root” genetic cause of a disease rather than its symptoms. To learn more about our science, click here.
RNAi is the core discovery that forms the therapies Alnylam is developing. It is recognized as a major scientific breakthrough—but how does it work, exactly?
Vision, Mission, and Values
Our Vision - Harnessing a revolution in biology for human health®.Our Mission - Build a top-tier, global, independent biopharmaceutical company founded on RNAi.
Our Core Values - Commitment to People, Innovation & Discovery, Sense of Urgency, Open Culture, and Passion for Excellence.
CAREERS AT ALNYLAM
Join Our Team and Grow With Us
At Alnylam, we are driven by our mission to translate the Nobel Prize-winning discovery of RNA interference (RNAi) into an innovative, new class of medicines. We’re motivated in this endeavor by the bravery and perseverance of people with unmet medical needs who live with rare and genetic diseases. They are the focus of our efforts, and we exist as a company because of them. That knowledge and commitment to patients is present in everything we do, every day.
At The Forefront of What’s Next
For Patients
Our goal, which is well underway, is to become a world-class biopharmaceutical company that can independently develop and deliver innovative medicines based on RNAi to patients worldwide. We have a deep pipeline of early to late stage investigational therapies, and 2018 marked the approval of our first medicine—the world’s first RNAi therapeutic. Even though we’ve been around since 2002, we’re just getting started!
For Employees
We are growing quickly and hiring across North America, Europe, Asia, and Latin America for a wide variety of roles. We’re seeking smart, passionate, “change the world” kind of people who are ready to say, “challenge accepted.” Our 1,500 (and counting!) employees are building a diverse, equitable, inclusive, and high-performing global organization that celebrates team achievement and recognizes individual contributions.
We’re at the forefront of what’s next for patients, and perhaps your career also.
Search among Alnylam Pharmaceuticals jobs
| Jobs: 21 - 30 of 81 |
Business Account Executive, TTR - San Antonio, TX
Cambridge, Massachusetts
Overview We are looking for experienced Business Account Executives (BAEs) with specialty sales experience to promote AMVUTTRA. hATTR patients often spend years undiagnosed and misdiagnosed. This is an amazing opportunity to educate and enh...
24d
Cambridge, Massachusetts
Overview The Drug Innovation group at Alnylam is seeking a passionate, creative post-doctoral scientist to join our highly interdisciplinary team focused on the advancement of our RNAi Platform and Lead Development efforts through novel app...
24d
Associate Director, Site and Monitoring Health
Cambridge, Massachusetts
Overview The Associate Director, Site and Monitoring Health will provide strong leadership, GCP expertise and clinical operations experience to drive the monitoring strategy for trials in their assigned program(s). They are responsible for ...
24d
Senior Medical Director, Global Rare
Cambridge, Massachusetts
Overview The Sr Med Dir, Global Rare, reporting to the VP, Global Rare Medical Lead, is responsible for providing global strategic and scientific support for the Ultra Rare franchise. This individual will drive key initiatives of the global...
24d
Legal Director, Global Medical Affairs & Pipeline
Cambridge, Massachusetts
The Legal Director, Global Medical Affairs & Pipeline will provide expert advice and strategic and tactical counseling to Global Medical Affairs teams to support compliance with applicable laws and regulations. This position will report to ...
24d
Cambridge, Massachusetts
Overview: The successful pathologist candidate will join an experienced team of pathologists providing discovery and development support on a strong pipeline of programs covering a large breadth of disease areas. In addition to routine path...
24d
Quality Control Analyst II, Reference Materials
Cambridge, Massachusetts
Overview The Quality Control Analyst II, Reference Materials in support of QC Raw Materials/Sample Management (QC-RMSM) plays a crucial role in sample management operations for our internal and external GMP laboratories. This role ensures h...
24d
Associate Director, Clinical Pharmacology
Cambridge, Massachusetts
Overview The Associate Director in Clinical Pharmacology position will support a rapidly expanding clinical portfolio of promising RNAi therapeutics. The candidate in this position should be well versed in clinical pharmacology, PK and PD w...
24d
Associate Director, Clinical Operations
Cambridge, Massachusetts
Overview The Associate Director is responsible for leading a team of Global Trial Leaders and Trial Managers within the Study Management Organization. The position is responsible for staff development and study oversight, and will work clos...
24d
Business Account Executive, Rare Disease - Minneapolis, MN
Cambridge, Massachusetts
Overview We are looking for an experienced and talented Business Account Executive (BAE) to commercially represent GIVLAARI and OXLUMO in the United States and have a significant impact on the lives of AHP patients. AHP's represent a sub-gr...
24d